{"id":97,"date":"2020-12-11T08:16:00","date_gmt":"2020-12-11T08:16:00","guid":{"rendered":"https:\/\/genekor.websters.gr\/?p=97"},"modified":"2024-03-06T09:22:19","modified_gmt":"2024-03-06T09:22:19","slug":"sabcs-rxponder-trial-study","status":"publish","type":"post","link":"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/","title":{"rendered":"SABCS \u2013 RxPONDER TRIAL Study"},"content":{"rendered":"\n

RxPONDER<\/strong> Study Results Demonstrate that the Oncotype DX\u00ae<\/sup> Test Can Now Spare Chemotherapy Use in the Majority of Women
with Node-positive Early-stage Breast Cancer <\/p>\n\n\n\n

\u2022 First results from the independent SWOG Cancer Research Network-led Phase III
study to be presented at the 2020 San Antonio Breast Cancer Symposium
\u2022 RxPONDER<\/strong> results from over 5,000 women likely to transform the treatment of
node-positive breast cancer, as the TAILORx study did in node-negative disease <\/p>\n\n\n\n

MADISON, Wis., December 9, 2020 \u2013 Exact Sciences Corp. (NASDAQ: EXAS) today announced that data from the Rx for Positive Node, Endocrine Responsive Breast Cancer, or RxPONDER<\/strong>, trial successfully defined the benefit of chemotherapy in early-stage, node-positive breast cancer patients with Oncotype DX Breast Recurrence Score\u00ae<\/sup> results of 0 to 25. First results from the study, led by the independent SWOG Cancer Research Network, and sponsoredby the National Cancer Institute (NCI), identified the majority of women with 1-3 positive nodes who received no benefit from chemotherapy.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

<\/h4>\n","protected":false},"excerpt":{"rendered":"

RxPONDER Study Results Demonstrate that the Oncotype DX\u00ae Test Can Now Spare Chemotherapy Use in the Majority of Womenwith Node-positive Early-stage Breast Cancer  \u2022 First results from the independent SWOG Cancer Research […]<\/p>\n","protected":false},"author":1,"featured_media":101,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-97","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-1"],"acf":[],"yoast_head":"\nSABCS - RxPONDER TRIAL Study - Genekor<\/title>\n<meta name=\"description\" content=\"RxPONDER Study Results Demonstrate that the Oncotype DX\u00aeTest Can Now Spare Chemotherapy Use in the Majority of Womenwith Node-positive Early-stage Breast Cancer.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/\" \/>\n<meta property=\"og:locale\" content=\"el_GR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SABCS - RxPONDER TRIAL Study\" \/>\n<meta property=\"og:description\" content=\"RxPONDER Study Results Demonstrate that the Oncotype DX\u00aeTest Can Now Spare Chemotherapy Use in the Majority of Womenwith Node-positive Early-stage Breast Cancer.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/\" \/>\n<meta property=\"og:site_name\" content=\"Genekor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/genekorbiotechnology\/\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-11T08:16:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-03-06T09:22:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/genekor.com\/wp-content\/uploads\/2020\/12\/oncotypedx.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1247\" \/>\n\t<meta property=\"og:image:height\" content=\"791\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Faykay22\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u03a3\u03c5\u03bd\u03c4\u03ac\u03c7\u03b8\u03b7\u03ba\u03b5 \u03b1\u03c0\u03cc\" \/>\n\t<meta name=\"twitter:data1\" content=\"Faykay22\" \/>\n\t<meta name=\"twitter:label2\" content=\"\u0395\u03ba\u03c4\u03b9\u03bc\u03ce\u03bc\u03b5\u03bd\u03bf\u03c2 \u03c7\u03c1\u03cc\u03bd\u03bf\u03c2 \u03b1\u03bd\u03ac\u03b3\u03bd\u03c9\u03c3\u03b7\u03c2\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 \u03bb\u03b5\u03c0\u03c4\u03ac\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/\"},\"author\":{\"name\":\"Faykay22\",\"@id\":\"https:\/\/genekor.com\/el\/#\/schema\/person\/86dcc4a1fea0667dffb2244541e4149e\"},\"headline\":\"SABCS \u2013 RxPONDER TRIAL Study\",\"datePublished\":\"2020-12-11T08:16:00+00:00\",\"dateModified\":\"2024-03-06T09:22:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/\"},\"wordCount\":159,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/genekor.com\/el\/#organization\"},\"image\":{\"@id\":\"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2020\/12\/oncotypedx.jpg\",\"articleSection\":[\"\u039c\u03b7 \u03ba\u03b1\u03c4\u03b7\u03b3\u03bf\u03c1\u03b9\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03bf\"],\"inLanguage\":\"el\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/\",\"url\":\"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/\",\"name\":\"SABCS - RxPONDER TRIAL Study - Genekor\",\"isPartOf\":{\"@id\":\"https:\/\/genekor.com\/el\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2020\/12\/oncotypedx.jpg\",\"datePublished\":\"2020-12-11T08:16:00+00:00\",\"dateModified\":\"2024-03-06T09:22:19+00:00\",\"description\":\"RxPONDER Study Results Demonstrate that the Oncotype DX\u00aeTest Can Now Spare Chemotherapy Use in the Majority of Womenwith Node-positive Early-stage Breast Cancer.\",\"breadcrumb\":{\"@id\":\"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/#breadcrumb\"},\"inLanguage\":\"el\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"el\",\"@id\":\"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/#primaryimage\",\"url\":\"https:\/\/genekor.com\/wp-content\/uploads\/2020\/12\/oncotypedx.jpg\",\"contentUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2020\/12\/oncotypedx.jpg\",\"width\":1247,\"height\":791},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/genekor.com\/el\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SABCS – RxPONDER TRIAL Study\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/genekor.com\/el\/#website\",\"url\":\"https:\/\/genekor.com\/el\/\",\"name\":\"Genekor\",\"description\":\"\u039c\u03bf\u03c1\u03b9\u03b1\u03ba\u03ae \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae\",\"publisher\":{\"@id\":\"https:\/\/genekor.com\/el\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/genekor.com\/el\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"el\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/genekor.com\/el\/#organization\",\"name\":\"Genekor\",\"url\":\"https:\/\/genekor.com\/el\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"el\",\"@id\":\"https:\/\/genekor.com\/el\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg\",\"contentUrl\":\"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg\",\"width\":1,\"height\":1,\"caption\":\"Genekor\"},\"image\":{\"@id\":\"https:\/\/genekor.com\/el\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/genekorbiotechnology\/\",\"https:\/\/gr.linkedin.com\/company\/genekor-sa\",\"https:\/\/www.youtube.com\/channel\/UCKC7sMFecVBY-OZAlRBHNzA\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/genekor.com\/el\/#\/schema\/person\/86dcc4a1fea0667dffb2244541e4149e\",\"name\":\"Faykay22\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"el\",\"@id\":\"https:\/\/genekor.com\/el\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9a60087a414006a2c76f910bb7465ef4?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9a60087a414006a2c76f910bb7465ef4?s=96&d=mm&r=g\",\"caption\":\"Faykay22\"},\"sameAs\":[\"https:\/\/genekor.websters.gr\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"SABCS - RxPONDER TRIAL Study - Genekor","description":"RxPONDER Study Results Demonstrate that the Oncotype DX\u00aeTest Can Now Spare Chemotherapy Use in the Majority of Womenwith Node-positive Early-stage Breast Cancer.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/","og_locale":"el_GR","og_type":"article","og_title":"SABCS - RxPONDER TRIAL Study","og_description":"RxPONDER Study Results Demonstrate that the Oncotype DX\u00aeTest Can Now Spare Chemotherapy Use in the Majority of Womenwith Node-positive Early-stage Breast Cancer.","og_url":"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/","og_site_name":"Genekor","article_publisher":"https:\/\/www.facebook.com\/genekorbiotechnology\/","article_published_time":"2020-12-11T08:16:00+00:00","article_modified_time":"2024-03-06T09:22:19+00:00","og_image":[{"width":1247,"height":791,"url":"https:\/\/genekor.com\/wp-content\/uploads\/2020\/12\/oncotypedx.jpg","type":"image\/jpeg"}],"author":"Faykay22","twitter_card":"summary_large_image","twitter_misc":{"\u03a3\u03c5\u03bd\u03c4\u03ac\u03c7\u03b8\u03b7\u03ba\u03b5 \u03b1\u03c0\u03cc":"Faykay22","\u0395\u03ba\u03c4\u03b9\u03bc\u03ce\u03bc\u03b5\u03bd\u03bf\u03c2 \u03c7\u03c1\u03cc\u03bd\u03bf\u03c2 \u03b1\u03bd\u03ac\u03b3\u03bd\u03c9\u03c3\u03b7\u03c2":"2 \u03bb\u03b5\u03c0\u03c4\u03ac"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/#article","isPartOf":{"@id":"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/"},"author":{"name":"Faykay22","@id":"https:\/\/genekor.com\/el\/#\/schema\/person\/86dcc4a1fea0667dffb2244541e4149e"},"headline":"SABCS \u2013 RxPONDER TRIAL Study","datePublished":"2020-12-11T08:16:00+00:00","dateModified":"2024-03-06T09:22:19+00:00","mainEntityOfPage":{"@id":"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/"},"wordCount":159,"commentCount":0,"publisher":{"@id":"https:\/\/genekor.com\/el\/#organization"},"image":{"@id":"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/#primaryimage"},"thumbnailUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2020\/12\/oncotypedx.jpg","articleSection":["\u039c\u03b7 \u03ba\u03b1\u03c4\u03b7\u03b3\u03bf\u03c1\u03b9\u03bf\u03c0\u03bf\u03b9\u03b7\u03bc\u03ad\u03bd\u03bf"],"inLanguage":"el","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/","url":"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/","name":"SABCS - RxPONDER TRIAL Study - Genekor","isPartOf":{"@id":"https:\/\/genekor.com\/el\/#website"},"primaryImageOfPage":{"@id":"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/#primaryimage"},"image":{"@id":"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/#primaryimage"},"thumbnailUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2020\/12\/oncotypedx.jpg","datePublished":"2020-12-11T08:16:00+00:00","dateModified":"2024-03-06T09:22:19+00:00","description":"RxPONDER Study Results Demonstrate that the Oncotype DX\u00aeTest Can Now Spare Chemotherapy Use in the Majority of Womenwith Node-positive Early-stage Breast Cancer.","breadcrumb":{"@id":"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/#breadcrumb"},"inLanguage":"el","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/"]}]},{"@type":"ImageObject","inLanguage":"el","@id":"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/#primaryimage","url":"https:\/\/genekor.com\/wp-content\/uploads\/2020\/12\/oncotypedx.jpg","contentUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2020\/12\/oncotypedx.jpg","width":1247,"height":791},{"@type":"BreadcrumbList","@id":"https:\/\/genekor.com\/el\/2020\/12\/11\/sabcs-rxponder-trial-study\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/genekor.com\/el\/"},{"@type":"ListItem","position":2,"name":"SABCS – RxPONDER TRIAL Study"}]},{"@type":"WebSite","@id":"https:\/\/genekor.com\/el\/#website","url":"https:\/\/genekor.com\/el\/","name":"Genekor","description":"\u039c\u03bf\u03c1\u03b9\u03b1\u03ba\u03ae \u0393\u03b5\u03bd\u03b5\u03c4\u03b9\u03ba\u03ae","publisher":{"@id":"https:\/\/genekor.com\/el\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genekor.com\/el\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"el"},{"@type":"Organization","@id":"https:\/\/genekor.com\/el\/#organization","name":"Genekor","url":"https:\/\/genekor.com\/el\/","logo":{"@type":"ImageObject","inLanguage":"el","@id":"https:\/\/genekor.com\/el\/#\/schema\/logo\/image\/","url":"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg","contentUrl":"https:\/\/genekor.com\/wp-content\/uploads\/2021\/09\/logo-black.svg","width":1,"height":1,"caption":"Genekor"},"image":{"@id":"https:\/\/genekor.com\/el\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/genekorbiotechnology\/","https:\/\/gr.linkedin.com\/company\/genekor-sa","https:\/\/www.youtube.com\/channel\/UCKC7sMFecVBY-OZAlRBHNzA"]},{"@type":"Person","@id":"https:\/\/genekor.com\/el\/#\/schema\/person\/86dcc4a1fea0667dffb2244541e4149e","name":"Faykay22","image":{"@type":"ImageObject","inLanguage":"el","@id":"https:\/\/genekor.com\/el\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/9a60087a414006a2c76f910bb7465ef4?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9a60087a414006a2c76f910bb7465ef4?s=96&d=mm&r=g","caption":"Faykay22"},"sameAs":["https:\/\/genekor.websters.gr"]}]}},"_links":{"self":[{"href":"https:\/\/genekor.com\/el\/wp-json\/wp\/v2\/posts\/97","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genekor.com\/el\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/genekor.com\/el\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/genekor.com\/el\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/genekor.com\/el\/wp-json\/wp\/v2\/comments?post=97"}],"version-history":[{"count":3,"href":"https:\/\/genekor.com\/el\/wp-json\/wp\/v2\/posts\/97\/revisions"}],"predecessor-version":[{"id":9157,"href":"https:\/\/genekor.com\/el\/wp-json\/wp\/v2\/posts\/97\/revisions\/9157"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/genekor.com\/el\/wp-json\/wp\/v2\/media\/101"}],"wp:attachment":[{"href":"https:\/\/genekor.com\/el\/wp-json\/wp\/v2\/media?parent=97"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/genekor.com\/el\/wp-json\/wp\/v2\/categories?post=97"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/genekor.com\/el\/wp-json\/wp\/v2\/tags?post=97"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}